Casado, E.
Blanch, J.
Carbonell, C.
Bastida, J. C.
Pérez-Castrillón, J. L.
Canals, L.
Lizán, L.
Article History
Received: 16 July 2020
Accepted: 30 December 2020
First Online: 27 February 2021
Declarations
:
: Blanch J has received consulting fees from: Amgen, Lilly, Lacer Farma, and gebro Pharma. Pérez-Castrillón JL has ownership or partnership of Farmalider and has received consulting fees from: Amgen, Lilly, MSD and FAES. Carbonell C has received consulting fees from Amgen and Rubió. Bastida JC has received fees as a speaker or remuneration for attendance to Congresses from: Almirall, Amgen, Boehringer, Bayer, Esteve, Grunenthal, GSK, FAES, Ferrer, MSD, Pfizer, Rovi and Recordati. Lizán L has received consulting fees from Novartis, Bristol Myers Squibb, Sanofi, Boehringer Ingelheim, Nestle Health Science, Celgene, Gilead and Merck; and has participated in speaker bureaus for Lilly, IESE, EADA and Roche. Casado E has received fees for lectures and/or participation in advisory boards from Amgen, Lilly, UCB, Rubió and Theramex. Canals L works at Amgen and hold stock in Amgen.